186 related articles for article (PubMed ID: 34900535)
41. Protective Effects of Fluvastatin on Reproductive Function in Obese Male Rats Induced by High-Fat Diet through Enhanced Signaling of mTOR.
Cui X; Long C; Zhu J; Tian J
Cell Physiol Biochem; 2017; 41(2):598-608. PubMed ID: 28214901
[TBL] [Abstract][Full Text] [Related]
42. Insulin-induced de novo lipid synthesis occurs mainly via mTOR-dependent regulation of proteostasis of SREBP-1c.
Dong Q; Majumdar G; O'Meally RN; Cole RN; Elam MB; Raghow R
Mol Cell Biochem; 2020 Jan; 463(1-2):13-31. PubMed ID: 31541353
[TBL] [Abstract][Full Text] [Related]
43. Emodin improves lipid and glucose metabolism in high fat diet-induced obese mice through regulating SREBP pathway.
Li J; Ding L; Song B; Xiao X; Qi M; Yang Q; Yang Q; Tang X; Wang Z; Yang L
Eur J Pharmacol; 2016 Jan; 770():99-109. PubMed ID: 26626587
[TBL] [Abstract][Full Text] [Related]
44. Carbenoxolone ameliorates hepatic lipid metabolism and inflammation in obese mice induced by high fat diet via regulating the JAK2/STAT3 signaling pathway.
Chen Y; Lu W; Jin Z; Yu J; Shi B
Int Immunopharmacol; 2019 Sep; 74():105498. PubMed ID: 31261036
[TBL] [Abstract][Full Text] [Related]
45. Re-evaluating the roles of proposed modulators of mammalian target of rapamycin complex 1 (mTORC1) signaling.
Wang X; Fonseca BD; Tang H; Liu R; Elia A; Clemens MJ; Bommer UA; Proud CG
J Biol Chem; 2008 Nov; 283(45):30482-92. PubMed ID: 18676370
[TBL] [Abstract][Full Text] [Related]
46. Phospho-mTOR: a novel target in regulation of renal lipid metabolism abnormality of diabetes.
Hao J; Zhu L; Li F; Liu Q; Zhao X; Liu S; Xing L; Feng X; Duan H
Exp Cell Res; 2013 Aug; 319(14):2296-306. PubMed ID: 23827786
[TBL] [Abstract][Full Text] [Related]
47. Identification of Akt-independent regulation of hepatic lipogenesis by mammalian target of rapamycin (mTOR) complex 2.
Yuan M; Pino E; Wu L; Kacergis M; Soukas AA
J Biol Chem; 2012 Aug; 287(35):29579-88. PubMed ID: 22773877
[TBL] [Abstract][Full Text] [Related]
48. LRG ameliorates steatohepatitis by activating the AMPK/mTOR/SREBP1 signaling pathway in C57BL/6J mice fed a high‑fat diet.
Hao T; Chen H; Wu S; Tian H
Mol Med Rep; 2019 Jul; 20(1):701-708. PubMed ID: 31180545
[TBL] [Abstract][Full Text] [Related]
49. Lack of ClC-2 Alleviates High Fat Diet-Induced Insulin Resistance and Non-Alcoholic Fatty Liver Disease.
Fu D; Cui H; Zhang Y
Cell Physiol Biochem; 2018; 45(6):2187-2198. PubMed ID: 29550812
[TBL] [Abstract][Full Text] [Related]
50. [Intervention of Huayu Qutan Recipe on liver SREBP-2 signal pathway of hyperlipidemia rats of pi deficiency syndrome].
Leng X; Jia LQ; Yang GL; Wang JY; Zhu ML; Wang Y; Xu Y
Zhongguo Zhong Xi Yi Jie He Za Zhi; 2015 Mar; 35(3):320-6. PubMed ID: 25951638
[TBL] [Abstract][Full Text] [Related]
51. Inhibition of SREBP by a small molecule, betulin, improves hyperlipidemia and insulin resistance and reduces atherosclerotic plaques.
Tang JJ; Li JG; Qi W; Qiu WW; Li PS; Li BL; Song BL
Cell Metab; 2011 Jan; 13(1):44-56. PubMed ID: 21195348
[TBL] [Abstract][Full Text] [Related]
52. Activation of mTOR modulates SREBP-2 to induce foam cell formation through increased retinoblastoma protein phosphorylation.
Ma KL; Liu J; Wang CX; Ni J; Zhang Y; Wu Y; Lv LL; Ruan XZ; Liu BC
Cardiovasc Res; 2013 Dec; 100(3):450-60. PubMed ID: 24068000
[TBL] [Abstract][Full Text] [Related]
53. Design, synthesis, and biological evaluation of novel tetrahydroprotoberberine derivatives to reduce SREBPs expression for the treatment of hyperlipidemia.
Ge H; Zhang W; Yuan K; Xue H; Cheng H; Chen W; Xie Y; Zhang J; Xu X; Yang P
Eur J Med Chem; 2021 Oct; 221():113522. PubMed ID: 33984804
[TBL] [Abstract][Full Text] [Related]
54. SCAP/SREBPs are Central Players in Lipid Metabolism and Novel Metabolic Targets in Cancer Therapy.
Cheng X; Li J; Guo D
Curr Top Med Chem; 2018; 18(6):484-493. PubMed ID: 29788888
[TBL] [Abstract][Full Text] [Related]
55. Glucagon regulates hepatic lipid metabolism via cAMP and Insig-2 signaling: implication for the pathogenesis of hypertriglyceridemia and hepatic steatosis.
Wang H; Zhao M; Sud N; Christian P; Shen J; Song Y; Pashaj A; Zhang K; Carr T; Su Q
Sci Rep; 2016 Sep; 6():32246. PubMed ID: 27582413
[TBL] [Abstract][Full Text] [Related]
56. Celastrol ameliorates liver metabolic damage caused by a high-fat diet through Sirt1.
Zhang Y; Geng C; Liu X; Li M; Gao M; Liu X; Fang F; Chang Y
Mol Metab; 2017 Jan; 6(1):138-147. PubMed ID: 28123944
[TBL] [Abstract][Full Text] [Related]
57. Co-regulation of SREBP-1 and mTOR ameliorates lipid accumulation in kidney of diabetic mice.
Wang H; Zhu L; Hao J; Duan H; Liu S; Zhao S; Liu Q; Liu W
Exp Cell Res; 2015 Aug; 336(1):76-84. PubMed ID: 26112216
[TBL] [Abstract][Full Text] [Related]
58. Map4k4 suppresses Srebp-1 and adipocyte lipogenesis independent of JNK signaling.
Danai LV; Guilherme A; Guntur KV; Straubhaar J; Nicoloro SM; Czech MP
J Lipid Res; 2013 Oct; 54(10):2697-707. PubMed ID: 23924694
[TBL] [Abstract][Full Text] [Related]
59. Ginsenoside Re lowers blood glucose and lipid levels via activation of AMP-activated protein kinase in HepG2 cells and high-fat diet fed mice.
Quan HY; Yuan HD; Jung MS; Ko SK; Park YG; Chung SH
Int J Mol Med; 2012 Jan; 29(1):73-80. PubMed ID: 21971952
[TBL] [Abstract][Full Text] [Related]
60. ATP-mediated protein kinase B Akt/mammalian target of rapamycin mTOR/p70 ribosomal S6 protein p70S6 kinase signaling pathway activation promotes improvement of locomotor function after spinal cord injury in rats.
Hu LY; Sun ZG; Wen YM; Cheng GZ; Wang SL; Zhao HB; Zhang XR
Neuroscience; 2010 Sep; 169(3):1046-62. PubMed ID: 20678995
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
